Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab

The use of biologic agents has enabled control of severe asthma, but there is a risk that eosinophilic granulomatosis with polyangiitis (EGPA) may be masked in some cases. We herein report a 71-year-old man who was administered dupilumab for 2 years to stabilize his asthma symptoms. A few months aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Miki, Ohshima, Nobuharu, Kawashima, Masahiro, Shiina, Meiko, Kitani, Masashi, Suzukawa, Maho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943368/
https://www.ncbi.nlm.nih.gov/pubmed/34393172
http://dx.doi.org/10.2169/internalmedicine.7990-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943368/
https://www.ncbi.nlm.nih.gov/pubmed/34393172
http://dx.doi.org/10.2169/internalmedicine.7990-21

Ejemplares similares